Dexcom wins FDA nod for 15-day CGM
April 10, 2025
Dexcom (Nasdaq: DXCM) today announced a significant regulatory milestone for its continuous glucose monitoring (CGM) technology.
Dexcom (Nasdaq: DXCM) today announced a significant regulatory milestone for its continuous glucose monitoring (CGM) technology.
Intuitive (Nasdaq: ISRG) announced today that it received FDA clearance for its fully wristed SP SureForm 45 stapler.
Merit Medical Systems (Nasdaq:MMSI) announced that it launched the Ventrax delivery system for cardiac interventions.
Findings reveal opportunities for new treatments of Parkinson’s and related neurodegenerative disorders
Innovative System Aims to Streamline PCR Testing Workflow and Enhance Laboratory Efficiency
Innovative Design Offers Precise Ventilation and Intuitive Operation for Diverse Surgical Settings